HU227973B1 - Indazolamidok és az ezeket tartalmazó gyógyszerek - Google Patents

Indazolamidok és az ezeket tartalmazó gyógyszerek Download PDF

Info

Publication number
HU227973B1
HU227973B1 HU0002057A HUP0002057A HU227973B1 HU 227973 B1 HU227973 B1 HU 227973B1 HU 0002057 A HU0002057 A HU 0002057A HU P0002057 A HUP0002057 A HU P0002057A HU 227973 B1 HU227973 B1 HU 227973B1
Authority
HU
Hungary
Prior art keywords
formula
compound
pharmaceutically acceptable
alkyl
compounds
Prior art date
Application number
HU0002057A
Other languages
English (en)
Hungarian (hu)
Inventor
Mario Pinza
Mario Brufani
Alessandra Alisi
Nicola Cazzolla
Marilena Giannangeli
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HUP0002057A2 publication Critical patent/HUP0002057A2/hu
Publication of HUP0002057A3 publication Critical patent/HUP0002057A3/hu
Publication of HU227973B1 publication Critical patent/HU227973B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Paints Or Removers (AREA)
HU0002057A 1997-04-15 1998-04-02 Indazolamidok és az ezeket tartalmazó gyógyszerek HU227973B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI000867A IT1291569B1 (it) 1997-04-15 1997-04-15 Indazolammidi come agenti serotoninergici
PCT/EP1998/002129 WO1998046589A2 (en) 1997-04-15 1998-04-02 Indazole amide compounds as serotoninergic agents

Publications (3)

Publication Number Publication Date
HUP0002057A2 HUP0002057A2 (hu) 2001-04-28
HUP0002057A3 HUP0002057A3 (en) 2002-01-28
HU227973B1 true HU227973B1 (hu) 2012-07-30

Family

ID=11376888

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002057A HU227973B1 (hu) 1997-04-15 1998-04-02 Indazolamidok és az ezeket tartalmazó gyógyszerek

Country Status (26)

Country Link
US (1) US6197769B1 (cg-RX-API-DMAC7.html)
EP (1) EP0975623B1 (cg-RX-API-DMAC7.html)
JP (2) JP4578581B2 (cg-RX-API-DMAC7.html)
KR (1) KR100563867B1 (cg-RX-API-DMAC7.html)
CN (1) CN1318416C (cg-RX-API-DMAC7.html)
AR (1) AR012426A1 (cg-RX-API-DMAC7.html)
AT (1) ATE219490T1 (cg-RX-API-DMAC7.html)
AU (1) AU740360B2 (cg-RX-API-DMAC7.html)
BG (1) BG64006B1 (cg-RX-API-DMAC7.html)
CA (1) CA2286870C (cg-RX-API-DMAC7.html)
CZ (1) CZ295190B6 (cg-RX-API-DMAC7.html)
DE (1) DE69806141T2 (cg-RX-API-DMAC7.html)
DK (1) DK0975623T3 (cg-RX-API-DMAC7.html)
EA (1) EA002352B1 (cg-RX-API-DMAC7.html)
ES (1) ES2178205T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20022654B (cg-RX-API-DMAC7.html)
HU (1) HU227973B1 (cg-RX-API-DMAC7.html)
IL (1) IL132127A (cg-RX-API-DMAC7.html)
IT (1) IT1291569B1 (cg-RX-API-DMAC7.html)
PL (1) PL193308B1 (cg-RX-API-DMAC7.html)
PT (1) PT975623E (cg-RX-API-DMAC7.html)
SK (1) SK284731B6 (cg-RX-API-DMAC7.html)
TR (1) TR199902546T2 (cg-RX-API-DMAC7.html)
UA (1) UA58550C2 (cg-RX-API-DMAC7.html)
WO (1) WO1998046589A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA982926B (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
MXPA03007621A (es) 2001-02-23 2003-12-04 Merck & Co Inc Antagonistas nr2b de n-metil-d-aspartato no arilheterociclicos n-sustituidos.
EP1390034A4 (en) * 2001-04-03 2005-07-13 Merck & Co Inc N-SUBSTITUTED NONARYL HETEROCYCLO AMIDYL-NMDA / NR2B ANTAGONISTS
ITMI20030287A1 (it) 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20030972A1 (it) 2003-05-15 2004-11-16 Acraf Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
ITMI20031468A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
DE602005016446D1 (de) * 2004-11-05 2009-10-15 Theravance Inc 5-HT4-Rezeptoragonistenverbindungen
DE602005014566D1 (de) * 2004-11-05 2009-07-02 Theravance Inc Chinolinon-carboxamid-verbindungen
ATE469897T1 (de) * 2004-12-22 2010-06-15 Theravance Inc Indazolcarbonsäureamidverbindungen
US20060183901A1 (en) * 2005-02-17 2006-08-17 Theravance, Inc. Crystalline form of an indazole-carboxamide compound
BRPI0608392A2 (pt) * 2005-03-02 2009-12-29 Theravance Inc compostos de quinolinona como agonistas do receptor 5-ht4
ITMI20062230A1 (it) * 2006-11-22 2008-05-23 Acraf Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende
UA99927C2 (uk) * 2007-11-12 2012-10-25 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Медикамент, який є активним при невропатичному болі
US8377968B2 (en) * 2008-06-02 2013-02-19 Zalicus Pharmaceuticals, Ltd. N-piperidinyl acetamide derivatives as calcium channel blockers
CA2833507A1 (en) * 2011-06-07 2012-12-13 Dainippon Sumitomo Pharma Co., Ltd. Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
WO2013124169A1 (en) * 2012-02-21 2013-08-29 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
EA024939B1 (ru) * 2012-02-21 2016-11-30 Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. 1h-индазол-3-карбоксамидные соединения в качестве ингибиторов гликогенсинтазы киназы 3-бета
WO2014134306A1 (en) 2013-03-01 2014-09-04 Zalicus Pharmaceuticals, Ltd. Heterocyclic inhibitors of the sodium channel
WO2021007487A1 (en) 2019-07-11 2021-01-14 Praxis Precision Medicines, Inc. Formulations of t-type calcium channel modulators and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103862D0 (en) * 1991-02-25 1991-04-10 Glaxo Group Ltd Chemical compounds
NZ243993A (en) * 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
WO1996038420A1 (en) * 1995-05-31 1996-12-05 Nisshin Flour Milling Co., Ltd. Indazole derivatives having monocyclic amino group
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici

Also Published As

Publication number Publication date
JP5237324B2 (ja) 2013-07-17
EA199900935A1 (ru) 2000-04-24
HK1027811A1 (en) 2001-01-23
SK284731B6 (sk) 2005-10-06
HUP0002057A2 (hu) 2001-04-28
EP0975623B1 (en) 2002-06-19
WO1998046589A2 (en) 1998-10-22
BG64006B1 (bg) 2003-09-30
KR20010006120A (ko) 2001-01-26
ITMI970867A1 (it) 1998-10-15
CZ362599A3 (cs) 2000-04-12
DE69806141T2 (de) 2003-01-30
AU740360B2 (en) 2001-11-01
US6197769B1 (en) 2001-03-06
IL132127A (en) 2005-06-19
CA2286870C (en) 2007-05-22
DK0975623T3 (da) 2002-10-14
JP2010195813A (ja) 2010-09-09
EA002352B1 (ru) 2002-04-25
KR100563867B1 (ko) 2006-03-24
IT1291569B1 (it) 1999-01-11
PT975623E (pt) 2002-10-31
AU7215998A (en) 1998-11-11
UA58550C2 (uk) 2003-08-15
SK142399A3 (en) 2000-08-14
EP0975623A2 (en) 2000-02-02
ATE219490T1 (de) 2002-07-15
DE69806141D1 (de) 2002-07-25
PL193308B1 (pl) 2007-01-31
CZ295190B6 (cs) 2005-06-15
WO1998046589A3 (en) 1999-01-28
CN1252798A (zh) 2000-05-10
JP4578581B2 (ja) 2010-11-10
IL132127A0 (en) 2001-03-19
JP2001518906A (ja) 2001-10-16
GEP20022654B (en) 2002-03-25
ES2178205T3 (es) 2002-12-16
CN1318416C (zh) 2007-05-30
AR012426A1 (es) 2000-10-18
PL336348A1 (en) 2000-06-19
CA2286870A1 (en) 1998-10-22
ZA982926B (en) 1998-10-09
TR199902546T2 (xx) 2000-05-22
HUP0002057A3 (en) 2002-01-28
BG103863A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
US8476279B2 (en) Phenyl-piperazine derivatives as serotonin reuptake inhibitors
JP5237324B2 (ja) セロトニン様作用薬としてのインダゾールアミド化合物
US6291464B1 (en) Aminopiperazine derivatives
PT1499589E (pt) Derivados de n- fenil ( piperidin-2-il ) metilbenzamida, sua preparação e sua aplicação em terapêutica
NZ519692A (en) Phenylpiperazinyl, -piperidinyl or -tetrahydropyridinyl derivatives
AU2152101A (en) Substituted phenyl-piperazine derivatives, their preparation and use
US6916822B2 (en) Phenoxyalkylamine derivatives useful as opioid δ receptor agonists
CA1177830A (en) Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
SI9300191A (sl) Novi amidoalkil- in imidoalkil-piperazini
EP1613594B1 (en) 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
EP0233413B1 (en) 3-(2-aminoethyl)indole and -indoline derivatives, processes for their preparation and pharmaceutical compositions containing them
SE437516B (sv) Analogiforfarande for framstellning av n-fenyl-n-(4-piperidyl)amidderivat
EP0746556B1 (en) Tricyclic compounds having affinity for the 5-ht1a receptor
CA1187079A (en) 2,3,4,5-tetrahydro-1h-pyrido[4,3-b] indole derivatives and their preparation
Pavé et al. Synthesis of aminopyrrolo [1, 2-a] thieno [3, 2-e] pyrazine derivatives as serotoninergic 5-HT7 ligands
JPH04211059A (ja) 新規なテトラヒドロピリジン誘導体
HK1027811B (en) Indazole amide compounds as serotoninergic agents
MXPA00012479A (en) Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees